Topics › Drug Policy
Commentary by James Craven
Commentary by Teri Moore
Harm Reduction Newsletter by Guy Bentley and Brian Fojtik
Commentary by Brian Fojtik
Commentary by Anthony Randazzo and Daniel Takash
Harm Reduction Newsletter by Guy Bentley
Policy Brief by Lauren Krisai
Commentary by Adrian Moore